Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Liminatus Pharma Inc. (LIMN) had Tangible Shareholders Equity of $-0.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.00M |
|
-- |
|
-- |
|
$-0.00M |
|
$0.00M |
|
-- |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
0.00M |
|
0.00M |
|
$-2.55 |
|
$-2.55 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$-0.00M |
|
|
Tangible Shareholders Equity |
$-0.00M |
$-0.00M |
|
0.00M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|